ReviewDigital health
Enhancing clinical decision-making in endometrial cancer through deep learning technology: A review of current research.
Review in Digital health. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Endometrial cancer (EC), a growing malignancy among women, underscores an urgent need for early detection and intervention, critical for enhancing patient outcomes and survival rates. Traditional diagnostic approaches, including ultrasound (US), magnetic resonance imaging (MRI), hysteroscopy, and histopathology, have been essential in establishing robust diagnostic and prognostic frameworks for EC. These methods offer detailed insights into tumor morphology, vital for clinical decision-making. However, their analysis relies heavily on the expertise of radiologists and pathologists, a process that is not only time-consuming and labor-intensive but also prone to human error. The emergence of deep learning (DL) in computer vision has significantly transformed medical image analysis, presenting substantial potential for EC diagnosis. DL models, capable of autonomously learning and extracting complex features from imaging and histopathological data, have demonstrated remarkable accuracy in discriminating EC and stratifying patient prognoses. This review comprehensively examines and synthesizes the current literature on DL-based imaging techniques for EC diagnosis and management. It also aims to identify challenges faced by DL in this context and to explore avenues for its future development. Through these detailed analyses, our objective is to inform future research directions and promote the integration of DL into EC diagnostic and treatment strategies, thereby enhancing the precision and efficiency of clinical practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.